[Common name] Amoxil and Clavulanate Potassium Tablets

[Ingredients] The product is a kind of compound preparation, each tablet containing 0.4g amoxilin and 0.057g potassium clavulanate (calculated on the basis of clavulanic acid) in each bag, and the ratio of them is 7:1.

[Indication] It is indicated for lower respiratory tract infections, otitis media and sinusitis caused by β-lactamase producing haemophilus or moraxella bovis; for skin and skin soft-tissue infection caused by staphylococcus, escherichia coli or Klebsiella produced byβ-lactamase; and for the urinary tract infection caused by escherichia coli and Klebsiella or enterobacteriaceae.

[Specification]0.2285g（C16H19N3O5S 0.4g and C8H9NO5 0.057g）

[Usage and Dosage] Take orally as follows: For adults and children with weight more than 40kg (or aged above 12), depending on the condition, 1-2 tablet(s) at each time (each containing 400mg amoxilin and 57mg potassium clavulanate), once every 12h, or follow the doctor’s advice.

[Package] Composite film packaging; (1) 6 tablets each, (2) 12 tablets each; (3) 24 tablets each

[Expiry Date] 24 months

[Executive Standard] Chinese Pharmacopoeia, Version 2010, Part II.

[Approval Document Number] G (J) H20010772